United States· US:79378-001_edddbf7e-e2dd-4ff7-80a0-d73c22fd40ce
CHOLBAM
A cholic acid product containing cholic acid, registered in United States by Mirum Pharmaceuticals Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cholic acid is registered in 11 of 19 countries.
Countries holding a registration under ATC A05AA03 (cholic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Cholic acid · ATC A05AA03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHOLIC ACID
- Manufacturer
- Mirum Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- A05AA03
- ATC class
- Cholic acid
- Defined daily dose
- 0.25 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11793780010290 CAPSULE in 1 BOTTLE (79378-001-02)
- ndc1179378-001-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
12 interactions on record for cholic acid.
Graded by severity as the source publishes them — 12 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cholic acid · interactions on record
12 records
- 12 moderate
Most severe, free to view
- SucralfateA02BX02moderate
- ColestyramineC10AC01moderate
- ColestipolC10AC02moderate
- ColesevelamC10AC04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cholic acid in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaORPHACOLTHERAVIA, Neuilly-sur-Seine
- BelgiumKolbam 50 mgASK Pharmaceuticals
- FinlandKolbamRetrophin Europe Limited
- United KingdomKolbam 50mg capsulesRetrophin Inc
- FranceORPHACOL 50 mg, géluleTHERAVIA
- SwedenOrphacol 50 mg Kapsel, hårdTheravia
- IrelandOrphacol 50 mg hard capsulesTheravia
- IcelandOrphacolLaboratoires CTRS
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Orphacol
- Iceland · Orphacol
- Liechtenstein · Orphacol
- Norway · Orphacol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e28fd1b-17bc-4b65-bca6-0965fb8d966e GET /v1/drugs/1e28fd1b-17bc-4b65-bca6-0965fb8d966e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "CHOLIC ACID",
"productndc": "79378-001",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA205750",
"marketing_category": "NDA"
}See everything about cholic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.